Distinctive binding properties of the negative allosteric modulator, [ 3 H]SB269,652, at recombinant dopamine D 3 receptors-Reference-Cited by-同舟云学术

Distinctive binding properties of the negative allosteric modulator, [ 3 H]SB269,652, at recombinant dopamine D 3 receptors

Published:2018-01 Issue: Volume:819 Page:181-189
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Fasciani Irene,Pietrantoni Ilaria,Rossi Mario,Mannoury la Cour Clotilde,Aloisi Gabriella,Marampon Francesco,Scarselli Marco,Millan Mark J.,Maggio Roberto

Funder

Institut de Recherches Servier

Publisher

Elsevier BV

Subject

Pharmacology

Reference48 articles.

1. Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D(1)/D(2)/D(3) receptors vs D(2)/D(3) receptors only: parallel observations from co-transfected human and native cerebral receptors;Aloisi;Neuropharmacology,2011

2. The physiology, signaling, and pharmacology of dopamine receptors;Beaulieu;Pharmacol. Rev.,2011

3. 3H-Naloxone benzoylhydrazone binding in MOR-1-transfected Chinese Hamster Ovary cells: evidence for G-protein-dependent antagonist binding;Brown;J. Pharmacol. Exp. Ther.,1998

4. Advances in G protein-coupled receptor allostery: from function to structure;Christopoulos;Mol. Pharmacol.,2014

5. [3H]S33084: a novel, selective and potent radioligand at cloned human dopamine D3 receptors;Cussac;Namyn Sehmiedebergs Arch. Pharmacol.,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on allosteric modulators of dopamine receptors so far;Health Science Reports;2024-03

2. Metabolic Side Effects of Olanzapine in Patients With Psychotic Disorders in Oman: A Retrospective Cohort Study;Angiology;2022-02-03

3. Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences;Pharmaceuticals;2021-03-08

4. Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics;Pharmaceuticals;2020-11-14

5. Allosteric Antagonism of the A2A Adenosine Receptor by a Series of Bitopic Ligands;Cells;2020-05-12